TG Therapeutics (TGTX) Enters Agreement with FDA Over TG-1101 Special Protocol Assessment
Tweet Send to a Friend
TG Therapeutics (Nasdaq: TGTX) announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) regarding ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE